Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F11%3A00002449" target="_blank" >RIV/00023001:_____/11:00002449 - isvavai.cz</a>

Výsledek na webu

<a href="http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/67971504.1/ben/cvp/2011/00000009/00000003/art00001/2B441E673361E6131332845653A524BB09FD3CDCA3.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf" target="_blank" >http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/67971504.1/ben/cvp/2011/00000009/00000003/art00001/2B441E673361E6131332845653A524BB09FD3CDCA3.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Popis výsledku v původním jazyce

An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevatednon-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is <2 mmol/l (<180 mg/dl). 3). For standardized postprandial testing, a single FTT meal should be given after an 8 h fast and should consist of 75 g

Název v anglickém jazyce

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Popis výsledku anglicky

An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevatednon-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is <2 mmol/l (<180 mg/dl). 3). For standardized postprandial testing, a single FTT meal should be given after an 8 h fast and should consist of 75 g

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Current vascular pharmacology

ISSN

1570-1611

e-ISSN

—

Svazek periodika

9

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

AE - Spojené arabské emiráty

Počet stran výsledku

13

Strana od-do

258-270

Kód UT WoS článku

000290656600001

EID výsledku v databázi Scopus

—